NASDAQ · Biotechnology

ESSA Pharma Inc. (EPIX) Stock

$0.20 -1.85% NASDAQ: EPIX Healthcare

ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer.

Valuation

MetricValue
Price$0.20
Market Cap$9.52M
P/E Ratio-0.87
P/B Ratio0.08
P/S Ratio0.00
EPS (TTM)$-0.64
52-Week High$6.45
52-Week Low$0.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.33%
ROA-9.39%
ROCE-11.37%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio69.07

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-23.0M$-37.0M$-35.0M$-32.0M$-34.0M
Net Profit$-23.0M$-37.0M$-35.0M$-27.0M$-29.0M
EPS$-1.04$-0.96$-0.80$-0.60$-0.64
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$81.0M$198.0M$170.0M$149.0M$128.0M
Total Liabilities$1.0M$4.0M$2.0M$3.0M$4.0M
Cash$56.0M$138.0M$57.0M$34.0M$104.0M
Borrowings$0$0$0$0$0

Latest News

Low-Cost Developed Markets or Emerging-Market Tech Exposure? VEA vs. IEMG Motley Fool · Jul 23, 2026 GE Vernova’s AI power trade has one weak link TheStreet · Jul 23, 2026 Flagstar Financial Earnings: What To Look For From FLG StockStory · Jul 23, 2026 Eni and KazMunayGas Reach Key Milestone at Kazakhstan Hybrid Power Plant Oilprice.com · Jul 23, 2026 Stand-On by ABC Display Crowned Best Tradeshow Floor ACCESS Newswire · Jul 23, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-17.0M$-25.0M$-29.0M$-20.0M$-23.0M
Investing Cash Flow$-22.0M$-35.0M$-52.0M$-4.0M$92.0M
Financing Cash Flow$-3.0M$-8.0M$0$0$1.0M
Net Cash Flow$3.0M$82.0M$-81.0M$-23.0M$70.0M
Free Cash Flow$-17.0M$-25.0M$-29.0M$-20.0M$-23.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.11
EV / EBITDA6.75
FCF Yield-116.08%
Quick Ratio69.07
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APGNApexigen, Inc. $0.39 +8.48% -0.24 $9.57M 0.00%
BIORBiora Therapeutics, Inc. $0.22 +0.00% 0.00 $994994 0.00%
CHROChannel Therapeutics Corporation $1.35 +7.14% -0.05 $8.90M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
CSCICOSCIENS Biopharma Inc. $2.72 +0.00% -0.35 $8.57M 0.00%

About ESSA Pharma Inc.

ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's primary drug candidate is EPI-7386, an oral treatment presently undergoing Phase I clinical trials. This investigational compound is intended for individuals suffering from metastatic castration-resistant prostate cancer. Furthermore, ESSA Pharma has established collaborative partnerships with organizations including Caris Life Sciences, Inc., Bayer Consumer Care AG, Janssen Research & Development, LLC, and Astellas Pharma Inc. Founded in 2009, the company's corporate offices are located in Vancouver, Canada.

ESSA Pharma Inc. is headquartered in CA.

ESSA Pharma Inc. (EPIX) stock trades at $0.20 with a market capitalization of $9.52M. The stock is valued at a price-to-earnings (P/E) ratio of -0.87, price-to-book of 0.08, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.18 and $6.45, and currently trades 96.9% below its 52-week high.

On profitability, ESSA Pharma Inc. generates a return on equity (ROE) of -9.33%, return on capital employed of -11.37%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.essapharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides